Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60

Yunhong Li1, Rui Zhang1, Xiaolin Hou2

  • 1Ningxia Key Laboratory of Cerebrocranial Diseases, Basic Medical College of Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.

Insights

Heat shock protein 60 (HSP60) released by activated microglia induces oligodendrocyte precursor cell (OPC) death. Blocking toll-like receptor 4 (TLR4) protects OPCs, suggesting HSP60-TLR4 signaling as a therapeutic target for white matter disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Reactive microglia are implicated in myelin-associated white matter disorders, causing injury to oligodendrocyte precursor cells (OPCs).
  • Extracellular heat shock protein 60 (HSP60) is released during cellular stress, but its role in the central nervous system, particularly in microglia-mediated OPC injury, is unknown.

Purpose of the Study:

  • To investigate the role of extracellular HSP60 released by microglia in oligodendrocyte precursor cell (OPC) apoptosis.
  • To elucidate the underlying molecular mechanisms, including the involvement of toll-like receptor 4 (TLR4) and the NFκB pathway.

Main Methods:

  • Co-culture systems, cell death assays, binding assays, immunochemistry, western blot, and ELISA were employed.
  • The study utilized lipopolysaccharide (LPS)-activated microglia and oligodendrocyte precursor cells (OPCs).
  • Toll-like receptor (TLR) 4 blocking antibody was used to assess its protective effects.

Main Results:

  • LPS-activated microglia released extracellular HSP60, which bound to OPCs and induced apoptosis.
  • Pretreatment with a TLR4 blocking antibody increased OPC viability.
  • Blocking TLR4 reduced HSP60-induced expression of NFκB, caspase 3, and proinflammatory cytokines.

Conclusions:

  • Microglia-released HSP60 mediates oligodendrocyte precursor cell (OPC) apoptosis via binding to TLR4 and activating the TLR4-NFκB signaling pathway.
  • HSP60 represents a potential therapeutic target for treating myelin-associated neurodegenerative diseases characterized by microglia activation.

Related Concept Videos